NCT03989167Active, not recruiting
Clinical Decision Support for Familial Hypercholesterolemia
Clinical Decision Support for Familial Hypercholesterolemia: A Cluster Randomized Trial in the Primary Care Setting
Source: ClinicalTrials.gov · Last updated 14 Oct 2026
Brief summary (registry, in English)
A cluster randomized study in the primary care setting to evaluate a computer-based clinical decision support system to aid in the identification and management of patients with FH. The primary outcome of the study is the number of patients diagnosed with FH thirty-six months after study initiation.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 472029 (actual)
- First submitted
- 15 Jun 2019
- Start date
- 6 Dec 2022
- Primary completion date
- 31 Mar 2026
- Lead sponsor
- University Hospital, Linkoeping
- Diseases
- Familial hypercholesterolaemia
- NCT number
- NCT03989167
What you commit to
- Study type: Interventional
- Participants enrolled: 472029
- From 6 Dec 2022 to the primary completion date, 31 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Primary care centers not using the Cambio Cosmic Electronic Health Record System.
Who the study is looking for
- Primary care centers in the county of Östergötland.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitetssjukhuset i Linkoping Coordinator of this site? Confirm its status | Linköping | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.